CDR Monitor™ is a convenient online reference for all Common Drug Review (CDR) activities including submissions and their current status, as well as final recommendations and recommendation criteria. It allows you to examine the approval process from initial submission to recommendation decision for public drug plan reimbursement. The database includes all drugs that have gone through the process or are currently being evaluated by the CDR.
||Easy Access via
Market Access Console